Cargando…

Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantation

BACKGROUND: The identification of the best strategy to manage cytomegalovirus infection is hampered by uncertainties regarding the risk/benefit ratios of universal prophylaxis versus preemptive therapy, the impact of indirect cytomegalovirus effects and the associated costs. This study investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henrique Pinto, Cahue, Tedesco-Silva Jr, Helio, Rosso Felipe, Claudia, Nicolau Ferreira, Alexandra, Cristelli, Marina, Almeida Viana, Laila, Aguiar, Wilson, Medina-Pestana, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427657/ https://www.ncbi.nlm.nih.gov/pubmed/27643978 http://dx.doi.org/10.1016/j.bjid.2016.08.007

Ejemplares similares

Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection
por: Nakamura, Mônica Rika, et al.
Publicado: (2022)

Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals
por: de Sandes-Freitas, Tainá Veras, et al.
Publicado: (2015)

The influence of clinical, environmental, and socioeconomic factors on five-year patient survival after kidney transplantation
por: Ruppel, Priscila, et al.
Publicado: (2018)

Predictive ability of severity scores and outcomes for mortality in kidney transplant recipients with coronavirus disease 2019 admitted to the intensive care unit: results from a Brazilian single-center cohort study
por: Peruzzo, Maria Bethânia, et al.
Publicado: (2022)

Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes
por: Teixeira, Cínthia Montenegro, et al.
Publicado: (2020)

Migratory pattern of the coronavirus disease 2019 and high fatality rates among kidney transplant recipients: report from the Brazilian Multicenter Cohort Study
por: Cristelli, Marina Pontello, et al.
Publicado: (2021)

Reviewing 15 years of experience with sirolimus
por: Tedesco Silva, Helio, et al.
Publicado: (2015)

Chikungunya in a kidney transplant recipient: a case report
por: Foresto, Renato Demarchi, et al.
Publicado: (2019)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

The impact of universal induction therapy on early hospital readmission of kidney transplant recipients
por: Tavares, Melissa Gaspar, et al.
Publicado: (2022)

Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study
por: Medina-Pestana, José, et al.
Publicado: (2021)

Challenges of Multidrug-resistant New Delhi Metallo-beta-Lactamase (NDM-1)-producing Enterobacteriaceae in Kidney Transplant Patients
por: Foresto, Renato Demarchi, et al.
Publicado: (2021)

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, I P, et al.
Publicado: (2018)

Impact of Hypertension on COVID-19 Burden in Kidney Transplant Recipients: An Observational Cohort Study
por: Aguiar-Brito, Isabella, et al.
Publicado: (2022)

Sex Differences among Overweight/Obese Kidney Transplant Recipients Requiring Oxygen Support Amid the COVID-19 Pandemic
por: Veronese-Araújo, Alexandre, et al.
Publicado: (2023)

Donor-Derived Transmission of Cryptococcus gattii sensu lato in Kidney Transplant Recipients
por: Santos, Daniel W.C.L., et al.
Publicado: (2020)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
por: Kumar, Lakshin, et al.
Publicado: (2023)

Clinical impact, reactogenicity and immunogenicity after the first CoronaVac dose in dialysis patients: a Phase IV prospective study
por: Medina-Pestana, José, et al.
Publicado: (2021)

The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation
por: Linhares, Kamilla, et al.
Publicado: (2021)

COVID-19 in Kidney Transplant Recipients With Diabetes Mellitus: A Propensity Score Matching Analysis
por: Rangel, Érika B., et al.
Publicado: (2022)

Oxygen Requirement in Overweight/Obese Kidney Transplant Recipients with COVID-19: An Observational Cohort Study
por: Veronese-Araújo, Alexandre, et al.
Publicado: (2023)

CMV Viral Load and Mortality after Hematopoietic Cell Transplantation: A Cohort Study in the Era of Preemptive Therapy
por: Green, Margaret L., et al.
Publicado: (2016)

Sepsis-like histoplasmosis in a kidney transplant patient
por: Fernandes, Ana Raquel, et al.
Publicado: (2018)

The Association Between Kidney Donor Profile Index and 1-y Graft Function
por: Foresto, Renato Demarchi, et al.
Publicado: (2023)

PB2424: ORAL VERSUS INTRAVENOUS ANTI-CMV PREEMPTIVE THERAPY IN ALLOGENEIC STEM CELL TRANSPLANT PATIENTS WITH CMV REACTIVATION: EXPERIENCE FROM NATIONAL CENTER OF BONE MARROW TRANSPLANTATION, TUNISIA.
por: Yosra Kanoun, Rimmel, et al.
Publicado: (2023)

Two-Hit Kidney Allograft Injury by SARS-CoV-2
por: Ribeiro, Bárbara, et al.
Publicado: (2023)

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients
por: Robin, Christine, et al.
Publicado: (2017)

Presumed cytomegalovirus retinitis late after kidney transplant
por: Silva, Filipa, et al.
Publicado: (2021)

Early Hospital Readmission (EHR) in kidney transplantation: a review article
por: Tavares, Melissa Gaspar, et al.
Publicado: (2020)

From non-preemptive to preemptive scheduling using synchronization synthesis
por: Černý, Pavol, et al.
Publicado: (2016)

Perioperative Comparison of Preemptive and Non-Preemptive Renal Transplant Recipients
por: Aytekin, Sami, et al.
Publicado: (2020)

Preemptive SARS patents
por: Brickley, Peg
Publicado: (2003)

Urological Complications Associated With Pyeloureterostomy Without Ipsilateral Nephrectomy in Renal Transplant Recipients
por: Neto, Hernani M., et al.
Publicado: (2022)

Preemptive Medicine for Cerebral Aneurysms
por: AOKI, Tomohiro, et al.
Publicado: (2016)

Non-Preemptive Tree Packing
por: Lendl, Stefan, et al.
Publicado: (2022)

1106. The incidence and risk factors associated with varicella zoster virus infection in kidney transplant recipients after 1-month acyclovir prophylaxis in a CMV preemptive therapy era
por: Kim, Haein, et al.
Publicado: (2020)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
por: Carbone, Javier
Publicado: (2016)

Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy
por: Bonezi, Vivian, et al.
Publicado: (2020)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_prfms1j6iscljr9eremt5mqs8u